GlassScriptPhysician profile
Barry R Rossman
NPI 1811911761
$1,972.10
in general payments reported to CMS, 2019-2025
33 companies · $376 in 2025
The $376 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $697 · 2020: $57.16 · 2021: $267 · 2022: $334 · 2023: $93.32 · 2024: $148 · 2025: $376.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $395 · Travel and Lodging: $222.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $394.95 |
| Travel and Lodging | $221.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $296.78 | 2019-2025 | |
| Allergan, INC. | $182.00 | 2019-2022 | |
| Teleflex LLC | $166.17 | 2021-2024 | Urolift |
| Janssen Biotech, INC. | $113.61 | 2019-2025 | Erleada |
| Olympus America INC. | $106.13 | 2021-2022 | |
| Laborie Medical Technologies Corp. | $102.16 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Ambu INC. | $95.50 | 2022 | |
| Astellas Pharma US INC | $84.31 | 2019-2021 | |
| Dendreon Pharmaceuticals LLC | $78.04 | 2019 | |
| Boston Scientific Corporation | $74.88 | 2021-2023 | Spaceoar Vue System - 10ml |
| 180 Medical, INC. | $64.01 | 2019-2022 | |
| Amgen INC. | $58.30 | 2019-2020 | |
| Tolmar, INC. | $54.97 | 2024-2025 | Eligard |
| Coloplast Corp | $54.69 | 2019-2023 | Speedicath |
| Abbvie INC. | $54.68 | 2022 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| C. R. Bard, INC. & Subsidiaries | $46.37 | 2025 | Magic3 Go Intermittent Urinary Catheter |
| Tolmar Pharmaceuticals, INC. | $39.39 | 2019-2021 | |
| Ethicon US, LLC | $33.22 | 2019 | |
| Pfizer INC. | $28.71 | 2019 | |
| Endo Pharmaceuticals INC. | $26.95 | 2019 | |
| Baxter Healthcare | $22.39 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $21.68 | 2019 | |
| Endo USA, INC. | $18.84 | 2025 | Xiaflex, Aveed |
| Antares Pharma, INC. | $18.30 | 2025 | Xyosted |
| Cook Medical LLC | $17.79 | 2022 | |
| Neotract INC. | $17.01 | 2019 | |
| Myovant Sciences INC. | $14.80 | 2022 | |
| Photocure INC | $14.07 | 2019 | |
| Dentsply Ih INC. | $14.04 | 2021 | |
| Avadel Specialty Pharmaceuticals, LLC | $13.94 | 2019 | |
| Palette Life Sciences, INC. | $13.63 | 2023 | |
| Metuchen Pharmaceuticals | $13.15 | 2020 | |
| Aytu Biopharma, INC. | $11.59 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barry Rossman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.